Atlas Trials

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Clinical trial NCT06962969 · COMPLETED

Trial details

NCT number
NCT06962969
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Advanced or Metastatic Breast Cancer
Start date
2025-06-30
Primary completion
2025-10-23
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.